Sei Investments CO Biocryst Pharmaceuticals Inc Transaction History

Sei Investments CO

$75.3 Billion
Q4 2024

A detailed history of Sei Investments CO transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Sei Investments CO holds 57,190 shares of BCRX stock, worth $517,569. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,190

Previous 55,653 2.76%

Holding current value

$517,569

Previous $422,000 1.9%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$7.03 - $8.43 $10,805 - $12,956	1,537 Added 2.76%	57,190 $430,000
Q3 2024 Nov 12, 2024	BUY	$6.41 - $8.69 $88,496 - $119,974	13,806 Added 32.99%	55,653 $422,000
Q2 2024 Aug 13, 2024	SELL	$4.13 - $6.79 $1,590 - $2,614	-385 Reduced 0.91%	41,847 $258,000
Q1 2024 May 07, 2024	BUY	$4.89 - $7.65 $15,012 - $23,485	3,070 Added 7.84%	42,232 $214,000
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $5,756 - $7,826	1,156 Added 3.04%	39,162 $234,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $73,883 - $87,207	11,011 Added 40.79%	38,006 $269,000
Q2 2023 Aug 11, 2023	SELL	$6.96 - $8.81 $114,902 - $145,444	-16,509 Reduced 37.95%	26,995 $190,000
Q1 2023 May 12, 2023	SELL	$7.94 - $11.84 $229,513 - $342,247	-28,906 Reduced 39.92%	43,504 $362,000
Q4 2022 Feb 10, 2023	BUY	$10.5 - $14.2 $485,383 - $656,423	46,227 Added 176.55%	72,410 $831,000
Q3 2022 Nov 14, 2022	SELL	$10.79 - $14.81 $34,884 - $47,880	-3,233 Reduced 10.99%	26,183 $330,000
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $388,479 - $880,357	-49,237 Reduced 62.6%	29,416 $311,000
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $496,213 - $848,198	42,925 Added 120.14%	78,653 $1.28 Million
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $496,447 - $686,501	-44,405 Reduced 55.41%	35,728 $495,000
Q3 2021 Nov 12, 2021	SELL	$14.21 - $17.65 $548,562 - $681,360	-38,604 Reduced 32.51%	80,133 $1.15 Million
Q2 2021 Aug 06, 2021	BUY	$9.5 - $17.24 $1.13 Million - $2.05 Million	118,737 New	118,737 $1.88 Million
Q3 2020 Nov 06, 2020	SELL	$3.43 - $5.53 $325,500 - $524,785	-94,898 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$1.9 - $5.61 $180,306 - $532,377	94,898 New	94,898 $452,000
Q2 2019 Aug 14, 2019	SELL	$2.91 - $9.15 $172,731 - $543,125	-59,358 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$7.38 - $9.72 $121,563 - $160,107	-16,472 Reduced 21.72%	59,358 $483,000
Q4 2018 Feb 13, 2019	BUY	$6.51 - $9.6 $493,653 - $727,968	75,830 New	75,830 $612,000
Q3 2018 Nov 08, 2018	SELL	$5.52 - $7.99 $3,245 - $4,698	-588 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$4.1 - $5.97 $2,410 - $3,510	588	588 $3,000

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

169M

Call Options Held

930K

Put Options Held

1.03M

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.68B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Biocryst Pharmaceuticals Inc Transaction History